A B.C. woman brought a claim for damages against her former psychiatrist to B.C. Supreme Court in the amount of approximately ...

A B.C. woman who bought several pairs of the same shoes in different colours, owned 25 Louis Vuitton bags and gambled away her home equity said a prescribed drug made her do so and sued her ...

Besides the five convenience features, the M9 also gets a frunk storage, which is also a first for the carmaker in India ...

In our experience, aripiprazole 30 mg/day is generally well tolerated and no significant differences in occurrence of adverse effects have been noted in the 10-30 mg/day range.

Abilify Maintena® 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of schizophrenia Aripiprazole’s new long-acting ...

Aripiprazole once-every-two-months LAI was shown to provide similar plasma concentrations, and therefore similar effectiveness, as well as a similar safety and tolerability profile to aripiprazole ...

Lupin has received the Food and Drug Administration’s clearance for Aripiprazole Tablets, 2 mg, 5 mg, 10 mg,15 mg, 20 mg and 30 mg, which is the generic of Otsuka’s Abilify.

A comparative dosing and titration chart of commonly used first-generation and second-generation antipsychotics.

The once-every-two-months, long-acting injectable formulation in 960 mg and 720 mg prefilled syringes delivers sustained plasma concentrations comparable that demonstrated in studies with ABILIFY ...

Otsuka America Pharmaceutical, Inc. and Lundbeck announce the U.S. Food and Drug Administration has approved the New Drug Application for ABILIFY ASIMTUFII® extended-release injectable suspension for ...

The 960 mg dosage aripiprazole two-month met the primary endpoint criteria establishing similarity of aripiprazole plasma concentrations and thus comparable effectiveness to aripiprazole once-monthly ...